{"id":"https://openalex.org/W4291732071","doi":"https://doi.org/10.1055/s-0038-1650330","title":"The Significance of Hypofibrinolysis for the Risk of Recurrence of Venous Thromboembolism","display_name":"The Significance of Hypofibrinolysis for the Risk of Recurrence of Venous Thromboembolism","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W4291732071","doi":"https://doi.org/10.1055/s-0038-1650330","mag":"2403936868","pmid":"https://pubmed.ncbi.nlm.nih.gov/8743187"},"language":"en","primary_location":{"id":"doi:10.1055/s-0038-1650330","doi":"https://doi.org/10.1055/s-0038-1650330","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0038-1650330","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083115765","display_name":"Sam Schulman","orcid":"https://orcid.org/0000-0002-8512-9043","observed_orcids":["https://orcid.org/0000-0002-8512-9043"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"S Schulman","raw_affiliation_strings":["The Departments of Internal Medicine and Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Departments of Internal Medicine and Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109132249","display_name":"B. Wiman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"B Wiman","raw_affiliation_strings":["The Departments of Internal Medicine and Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Departments of Internal Medicine and Clinical Chemistry and Blood Coagulation, Karolinska Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"last","author":{"id":null,"display_name":"the Duration of Anticoagulation (DURAC) Trial Study Group","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"the Duration of Anticoagulation (DURAC) Trial Study Group","raw_affiliation_strings":["The Departments of Internal Medicine and Clinical Chemistry and Blood Coagulation,\n               Karolinska Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Departments of Internal Medicine and Clinical Chemistry and Blood Coagulation,\n               Karolinska Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1335113835"],"apc_list":null,"apc_paid":null,"fwci":5.5468,"has_fulltext":false,"cited_by_count":86,"citation_normalized_percentile":{"value":0.96518375,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"75","issue":"04","first_page":"607","last_page":"611"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.021299999207258224,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11721","display_name":"Blood properties and coagulation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9710000157356262},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.49900001287460327},{"id":"https://openalex.org/keywords/hypofibrinolysis","display_name":"hypofibrinolysis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/tissue-plasminogen-activator","display_name":"tissue plasminogen activator","score":0.9300000071525574},{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.9430000185966492},{"id":"https://openalex.org/keywords/venous-occlusion","display_name":"venous occlusion","score":0.9309999942779541},{"id":"https://openalex.org/keywords/fibrinolytic-capacity","display_name":"fibrinolytic capacity","score":0.8220000267028809},{"id":"https://openalex.org/keywords/oral-anticoagulation","display_name":"oral anticoagulation","score":0.8640000224113464},{"id":"https://openalex.org/keywords/risk-prediction","display_name":"risk prediction","score":0.699999988079071},{"id":"https://openalex.org/keywords/age-as-confounder","display_name":"age as confounder","score":0.6610000133514404},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6539999842643738},{"id":"https://openalex.org/keywords/post-thrombotic-syndrome","display_name":"post-thrombotic syndrome","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8505136966705322},{"id":"https://openalex.org/C2991741193","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thromboembolism","level":3,"score":0.6738767623901367},{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.6512078046798706},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6414280533790588},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6266892552375793},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5517942905426025},{"id":"https://openalex.org/C2776825266","wikidata":"https://www.wikidata.org/wiki/Q1410794","display_name":"Fibrinolysis","level":2,"score":0.4966164231300354},{"id":"https://openalex.org/C2780011451","wikidata":"https://www.wikidata.org/wiki/Q2751330","display_name":"Venous thrombosis","level":3,"score":0.48007044196128845},{"id":"https://openalex.org/C2776572282","wikidata":"https://www.wikidata.org/wiki/Q416351","display_name":"Tissue plasminogen activator","level":2,"score":0.4337160587310791},{"id":"https://openalex.org/C2780868729","wikidata":"https://www.wikidata.org/wiki/Q261327","display_name":"Thrombosis","level":2,"score":0.42144206166267395},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3518202602863312},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22484034299850464}],"mesh":[{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005342","descriptor_name":"Fibrinolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013923","descriptor_name":"Thromboembolism","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D014689","descriptor_name":"Venous Insufficiency","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1055/s-0038-1650330","doi":"https://doi.org/10.1055/s-0038-1650330","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0038-1650330","pdf_url":null,"source":{"id":"https://openalex.org/S206235894","display_name":"Thrombosis and Haemostasis","issn_l":"0340-6245","issn":["0340-6245","2567-689X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and Haemostasis","raw_type":"journal-article"},{"id":"pmid:8743187","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8743187","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thrombosis and haemostasis","raw_type":"Clinical Trial"},{"id":"mag:2403936868","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8743187","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2403936868","https://openalex.org/W2079175463","https://openalex.org/W1836649737","https://openalex.org/W2979914263","https://openalex.org/W842512883","https://openalex.org/W2443321861","https://openalex.org/W1965875288","https://openalex.org/W2417963531","https://openalex.org/W2120294252","https://openalex.org/W2946719672"],"abstract_inverted_index":{"An":[0],"impaired":[1],"fibrinolytic":[2,25,225],"function":[3],"has":[4],"been":[5,114],"described":[6],"in":[7,76,145,157,206,239,289,308],"several":[8],"case-control":[9],"studies":[10],"of":[11,37,48,69,102,132,201,264,284,294,305],"patients":[12,153,202,240,315],"with":[13,124,160,197,209,241,271,292],"venous":[14,49],"thromboembolism":[15],"(VTE).":[16],"In":[17,180,280],"the":[18,21,66,72,106,158,181,207,224,266,269,298,303,313],"present":[19],"study":[20],"correlations":[22],"between":[23,253,268],"some":[24],"compounds":[26],"and":[27,44,52,78,92,119,140,210,223,242,255,261,272,286],"future":[28,310],"recurrent":[29,74,120,295],"VTE":[30,70,75,296],"were":[31,60,83,122,151,236],"investigated.":[32],"Blood":[33],"samples":[34,146],"for":[35,85,110,135,143,188,312],"analysis":[36,263],"tissue-type":[38],"plasminogen":[39,53],"activator":[40,54],"(t-PA)":[41],"antigen":[42,137,192,219,228,233,257,278,288],"before":[43,138,234],"after":[45,65,221,229],"10":[46,204],"min":[47],"occlusion":[50],"(V.O.)":[51],"inhibitor":[55],"type":[56],"1":[57],"(PAI-1)":[58],"activity":[59],"taken":[61,147],"at":[62,148,193],"6":[63,88,93,189],"months":[64,89,94],"first":[67,73],"episode":[68],"or":[71,87,95],"784":[77],"207":[79],"patients,":[80,183],"respectively,":[81],"who":[82,184],"anticoagulated":[84],"1.5":[86],"(first":[90,97],"VTE)":[91],"indefinitely":[96],"recurrence).":[98],"During":[99],"a":[100,248],"follow-up":[101],"3-6":[103,300],"years":[104],"from":[105],"event":[107],"which":[108],"qualified":[109],"inclusion":[111],"there":[112,150],"have":[113],"177":[115],"recurrences.":[116,245],"All":[117],"initial":[118],"events":[121,311],"verified":[123],"objective":[125],"diagnostic":[126],"methods.":[127],"Using":[128],"cut":[129],"off":[130],"points":[131],"10.0":[133],"ng/ml":[134,205],"t-PA":[136,191,218,232,256,277,287],"V.O.":[139,222,230],"30":[141],"AU/ml":[142],"PAI-1":[144,285],"rest,":[149],"more":[152],"above":[154,203],"those":[155],"levels":[156,220,283],"groups":[159,208,270],"than":[161],"without":[162,211,243,273],"further":[163,274],"recurrence":[164,275],"(t-PA":[165,227],"antigen,":[166],"50%":[167],"versus":[168,175,199],"36%,":[169],"p":[170,177],"=":[171,178],"0.001;":[172],"PAI-1,":[173],"18%":[174],"12%,":[176],"0.045).":[179],"495":[182],"received":[185],"oral":[186],"anticoagulation":[187],"months,":[190],"rest":[194],"discriminated":[195],"better,":[196],"59%":[198],"34%":[200],"recurrence,":[212],"respectively":[213],"(p":[214,258],"<":[215,259],"0.001).":[216],"The":[217],"capacity":[226],"minus":[231],"V.O.)":[235],"distributed":[237],"similarly":[238],"new":[244],"There":[246],"was":[247],"statistically":[249],"significant":[250],"positive":[251],"correlation":[252],"age":[254],"0.001),":[260],"by":[262],"covariance":[265],"difference":[267],"regarding":[276],"disappeared.":[279],"conclusion,":[281],"increased":[282],"VTE-patients":[290],"correlate":[291],"development":[293],"within":[297],"next":[299],"years,":[301],"but":[302],"value":[304],"these":[306],"components":[307],"predicting":[309],"individual":[314],"is":[316],"limited.":[317]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2022-08-16T00:00:00"}